0.8199
price down icon26.79%   -0.3001
pre-market  プレマーケット:  .77   -0.0499   -6.09%
loading

Promis Neurosciences Inc (PMN) 最新ニュース

pulisher
12:09 PM

Is ProMIS Neurosciences Inc. a good long term investmentHigh-yield market plays - jammulinksnews.com

12:09 PM
pulisher
Jul 22, 2025

Earnings Misses And Clinical Hurdles Rattle Major Stocks - Finimize

Jul 22, 2025
pulisher
Jul 22, 2025

Still undervalued? ProMIS Neurosciences keeps $9.50 target price at Leede - Cantech Letter

Jul 22, 2025
pulisher
Jul 22, 2025

Alzheimer’s stock triples after FDA Fast-Track Designation - MSN

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences Plunges 24.56% Intraday—Is the FDA Fast Track Outpacing Investor Sentiment? - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences Plunges 30.5% Intraday—What Storm Clouds Loom Over a Biotech Betting on Alzheimer’s Innovation? - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

What makes ProMIS Neurosciences Inc. stock price move sharplyBreakout Level Watch - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Buy Rating for ProMIS Neurosciences Driven by Fast Track Designation and Promising Alzheimer’s Treatment Potential - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences Announces Private Placement Financing - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences announces $0.8M registered direct offering - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences announces private placement financing - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences stock gets FDA Fast Track designation for PMN310 - Investing.com

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences (PMN) Secures Funding to Enhance Therapeuti - GuruFocus

Jul 22, 2025
pulisher
Jul 22, 2025

What drives ProMIS Neurosciences Inc. stock priceFree Stock Index Interpretation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences Announces $0.8 Million Registered Direct Offering, Priced At-the-Market Under Nasdaq Rules - The Manila Times

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences Announces Private Placement Financing | PMN Stock News - GuruFocus

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences Announces $2.4 Million PIPE Financing for Clinical Development of PMN310 - Nasdaq

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences Drops 9.82% Amid ICICI Bank's Strong Earnings - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences Gains FDA Fast Track for PMN310 - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Secures $9.2M Funding Boost: Accelerates Novel Alzheimer's Treatment Development - Stock Titan

Jul 22, 2025
pulisher
Jul 22, 2025

Alzheimer's Treatment Pioneer ProMIS Secures New Funding to Accelerate PMN310 Clinical Trials - Stock Titan

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences ends at-the-market agreement and receives FDA fast track for PMN310 - Investing.com Australia

Jul 22, 2025
pulisher
Jul 22, 2025

3 Penny Stocks to Watch Now, 7/22/25 - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about ProMIS Neurosciences Inc. stockExceptional return forecasts - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

ProMIS Neurosciences Inc. Stock Analysis and ForecastFree AI-Backed Trading Signals - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences Inc Inc. (PMN) Price Performance: The Role of Supply and Demand - investchronicle.com

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences shares surge 149.77% intraday after FDA grants Fast Track designation to PMN310 for Alzheimer’s treatment. - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Shares Of Micro Cap Biotech Surge After Breakthrough FDA Designation - The Globe and Mail

Jul 21, 2025
pulisher
Jul 21, 2025

Alzheimer’s stock triples after FDA Fast-Track Designation | 2025-07-21 | Investing News - Stockhouse

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences Soars 134%—What’s Fueling This Biotech Breakout? - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences (PMN) up more than 300% since Jul 8 - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Promis Neurosciences shares surge 250% intraday after FDA grants Fast Track designation for PMN310 Alzheimer's treatment. - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences: Stock Surge Insight - StocksToTrade

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences Soars 157% on FDA Fast Track Designation – What’s Fueling This Volatile Rally? - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences Surges: Analyzing Recent Moves - timothysykes.com

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences shares surge 21.37% premarket after FDA grants Fast Track designation to PMN310 for Alzheimer’s treatment. - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences stock price surges in pre market trading as company receives FDA fast track designation for alzheimer’s drug candidate PMN310 - MSN

Jul 21, 2025
pulisher
Jul 21, 2025

Why Is ProMIS Neurosciences Stock (PMN) Up 180% Today? - TipRanks

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences shares surge 17.50% premarket after FDA grants Fast Track designation to PMN310 for Alzheimer’s treatment. - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences stock soars after FDA grants Fast Track for Alzheimer’s drug - Investing.com India

Jul 21, 2025
pulisher
Jul 21, 2025

Why ProMIS Is Rising In Pre-market? - Nasdaq

Jul 21, 2025
pulisher
Jul 21, 2025

FDA grants fast track designation to ProMIS Neurosciences’ Alzheimer’s drug By Investing.com - Investing.com South Africa

Jul 21, 2025
pulisher
Jul 21, 2025

FDA grants fast track designation to ProMIS Neurosciences’ Alzheimer’s drug - Investing.com Australia

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences granted Fast Track designation by FDA for PMN310 - TipRanks

Jul 21, 2025
pulisher
Jul 21, 2025

ProMIS Neurosciences Granted Fast Track Designation by U.S. - GlobeNewswire

Jul 21, 2025
pulisher
Jul 21, 2025

FDA Fast-Tracks Revolutionary Alzheimer's Drug Promising Fewer Side Effects Than Current Treatments - Stock Titan

Jul 21, 2025
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
大文字化:     |  ボリューム (24 時間):